Risk factors for breast cancer subtypes by race and ethnicity: a scoping review

被引:1
|
作者
Hurson, Amber N. [1 ]
Ahearn, Thomas U. [1 ]
Koka, Hela [1 ]
Jenkins, Brittany D. [1 ,2 ,3 ]
Harris, Alexandra R. [1 ]
Roberts, Sylvia [1 ]
Fan, Sharon [1 ]
Franklin, Jamirra [3 ]
Butera, Gisela [4 ]
Keeman, Renske [5 ]
Jung, Audrey Y. [6 ]
Middha, Pooja [7 ]
Gierach, Gretchen L. [1 ]
Yang, Xiaohong R. [1 ]
Chang-Claude, Jenny [6 ]
Tamimi, Rulla M. [8 ]
Troester, Melissa A. [9 ]
Bandera, Elisa, V [10 ]
Abubakar, Mustapha [1 ]
Schmidt, Marjanka K. [5 ,11 ]
Garcia-Closas, Montserrat [1 ,12 ]
机构
[1] NCI, Div Canc Epidemiol & Genet, 9609 Med Ctr Dr,Rm 7-E238,MSC 9774, Rockville, MD 20892 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD USA
[3] NCI, Lab Human Carcinogenesis, Ctr Canc Res, Bethesda, MD USA
[4] Natl Inst Hlth Lib, Off Res Serv, NIH, Bethesda, MD USA
[5] Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands
[6] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany
[7] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[8] Weill Cornell Med, Dept Populat Hlth Sci, New York, NY USA
[9] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA
[10] Rutgers Canc Inst New Jersey, Sect Canc Epidemiol & Hlth Outcomes, New Brunswick, NJ USA
[11] Leiden Univ, Dept Clin Genet, Med Ctr, Leiden, Netherlands
[12] Inst Canc Res, Div Genet & Epidemiol, London, England
关键词
RECEPTOR STATUS; PREMENOPAUSAL WOMEN; TUMOR SUBTYPE; ESTROGEN; INVOLUTION; ASSOCIATION; PREGNANCY; OBESITY; SERUM; WHITE;
D O I
10.1093/jnci/djae172
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Breast cancer consists of distinct molecular subtypes. Studies have reported differences in risk factor associations with breast cancer subtypes, especially by tumor estrogen receptor (ER) status, but their consistency across racial and ethnic populations has not been comprehensively evaluated.Methods We conducted a qualitative, scoping literature review using the Preferred Reporting Items for Systematic Reviews and Meta-analysis, extension for Scoping Reviews to investigate consistencies in associations between 18 breast cancer risk factors (reproductive, anthropometric, lifestyle, and medical history) and risk of ER-defined subtypes in women who self-identify as Asian, Black or African American, Hispanic or Latina, or White. We reviewed publications between January 1, 1990 and July 1, 2022. Etiologic heterogeneity evidence (convincing, suggestive, none, or inconclusive) was determined by expert consensus.Results Publications per risk factor ranged from 14 (benign breast disease history) to 66 (parity). Publications were most abundant for White women, followed by Asian, Black or African American, and Hispanic or Latina women. Etiologic heterogeneity evidence was strongest for parity, followed by age at first birth, postmenopausal body mass index, oral contraceptive use, and estrogen-only and combined menopausal hormone therapy. Evidence was limited for other risk factors. Findings were consistent across racial and ethnic groups, although the strength of evidence varied.Conclusion The literature supports etiologic heterogeneity by ER for some established risk factors that are consistent across race and ethnicity groups. However, in non-White populations evidence is limited. Larger, more comparable data in diverse populations are needed to better characterize breast cancer etiologic heterogeneity.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Breast cancer histolological subtypes by race/ethnicity
    Parise, Carol
    Caggiano, Vincent
    [J]. CANCER RESEARCH, 2015, 75
  • [2] Variation in breast cancer subtypes with age and race/ethnicity
    Parise, Carol A.
    Bauer, Katrina R.
    Caggiano, Vincent
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2010, 76 (01) : 44 - 52
  • [3] Validation of Breast Cancer Risk Models by Race/Ethnicity, Family History and Molecular Subtypes
    McCarthy, Anne Marie
    Liu, Yi
    Ehsan, Sarah
    Guan, Zoe
    Liang, Jane
    Huang, Theodore
    Hughes, Kevin
    Semine, Alan
    Kontos, Despina
    Conant, Emily
    Lehman, Constance
    Armstrong, Katrina
    Braun, Danielle
    Parmigiani, Giovanni
    Chen, Jinbo
    [J]. CANCERS, 2022, 14 (01)
  • [4] Incident Cardiometabolic Risk Factors in Breast Cancer Patients Stratified by Race and Ethnicity
    Diaz, Andrea E.
    Kwan, Marilyn L.
    Laurent, Cecile A.
    Roh, Janise M.
    Iribarren, Carlos
    Rana, Jamal S.
    Kushi, Lawrence H.
    Reding, Kerryn
    Rillamas-Sun, Eileen
    Quesenberry, Charles P.
    [J]. CIRCULATION, 2023, 148
  • [5] Reproductive risk factors and breast cancer subtypes: a review of the literature
    Kristin N. Anderson
    Richard B. Schwab
    Maria Elena Martinez
    [J]. Breast Cancer Research and Treatment, 2014, 144 : 1 - 10
  • [6] Reproductive risk factors and breast cancer subtypes: a review of the literature
    Anderson, Kristin N.
    Schwab, Richard B.
    Martinez, Maria Elena
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2014, 144 (01) : 1 - 10
  • [7] Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer
    Menikdiwela, Kalhara. R. R.
    Kahathuduwa, Chanaka
    Bolner, Michelle. L. L.
    Rahman, Rakhshanda Layeequr
    Moustaid-Moussa, Naima
    [J]. BIOMEDICINES, 2022, 10 (11)
  • [9] Differences in Gene and Protein Expression and the Effects of Race/Ethnicity on Breast Cancer Subtypes
    Chavez-MacGregor, Mariana
    Liu, Shuying
    De Melo-Gagliato, Debora
    Chen, Huiqin
    Do, Kim-Anh
    Pusztai, Lajos
    Symmans, W. Fraser
    Nair, Lakshmy
    Hortobagyi, Gabriel N.
    Mills, Gordon B.
    Meric-Bernstam, Funda
    Gonzalez-Angulo, Ana M.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (02) : 316 - 323
  • [10] Age at menarche and risk of young-onset breast cancer subtypes overall and by race/ethnicity and socioeconomic position
    Zhang, Zhenzhen
    Post, Lydia R. Marcus
    Pathak, Dorothy R.
    Hamilton, Ann S.
    Hirko, Kelly A.
    Houang, Richard
    Olson, L. Karl
    Schedin, Pepper
    Schwartz, Ann G.
    Velie, Ellen M.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (09)